Research, both clinical and genetic, has linked the catalytic subunit of NuRD, Chromodomain helicase DNA-binding protein 4 (CHD4), with congenital heart disease (CHD), specifically atrial and ventricular septal abnormalities (71). Here, CHD4 is linked to coronary artery disorder.